Hypertension, Vol 11, 312-319, Copyright © 1988 by American Heart Association
JR Gill Jr, G Gullner, CR Lake, DJ Lakatua and G Lan
Nineteen patients with normal renin idiopathic hypertension were
arbitrarily classified as salt-sensitive or salt-resistant depending on
whether their mean arterial pressure did or did not increase by 8% or more
when sodium intake was increased. The responses of the two subsets and of
five normal subjects to sodium intakes of 9, 109, and 249 mEq/day given for
7 days were as follows: The salt-sensitive subjects retained more sodium
than normal and plasma or urinary norepinephrine did not decrease when they
were given a high sodium intake; urinary dopamine was normal but did not
increase normally when sodium intake was increased. The salt-resistant
subjects excreted sodium normally and plasma and urinary norepinephrine was
decreased by 30 and 37%, respectively, when they were given a high sodium
intake; urinary dopamine was supernormal and did not increase further when
sodium intake was increased. Cumulative sodium retention during the high
sodium intake was directly related to the percentage of change in plasma
norepinephrine in the hypertensive subjects, suggesting that renal
adrenergic activity was a factor in the impaired sodium excretion in the
salt-sensitive patients. Cumulative sodium retention and the percentage of
change in plasma norepinephrine were inversely related to urinary dopamine
in the hypertensive subjects, suggesting that increased formation of
dopamine in renal and neural tissue in the salt- resistant subjects may
have been responsible for the differences between the subsets in renal and
adrenergic responses to a high sodium intake.(ABSTRACT TRUNCATED AT 250
WORDS)
ARTICLES
Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension
Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892.
This article has been cited by other articles:
![]() |
A. J. King, M. Novotny, G. M. Swain, and G. D. Fink Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1262 - R1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pinho, P. Gomes, M. P. Serrao, M. J. Bonifacio, and P. Soares-da-Silva Organ-Specific Overexpression of Renal LAT2 and Enhanced Tubular L-DOPA Uptake Precede the Onset of Hypertension Hypertension, October 1, 2003; 42(4): 613 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gomes, J. Xu, P. Serrao, S. Doria, P. A. Jose, and P. Soares-da-Silva Expression and function of sodium transporters in two opossum kidney cell clonal sublines Am J Physiol Renal Physiol, July 1, 2002; 283(1): F73 - F85. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey Renal Dopamine System: Paracrine Regulator of Sodium Homeostasis and Blood Pressure Hypertension, September 1, 2001; 38(3): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chiolero, G. Wurzner, and M. Burnier Renal determinants of the salt sensitivity of blood pressure Nephrol. Dial. Transplant., March 1, 2001; 16(3): 452 - 458. [Full Text] [PDF] |
||||
![]() |
F. M. Sacks, L. P. Svetkey, W. M. Vollmer, L. J. Appel, G. A. Bray, D. Harsha, E. Obarzanek, P. R. Conlin, E. R. Miller, D. G. Simons-Morton, et al. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet N. Engl. J. Med., January 4, 2001; 344(1): 3 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Soares-Da-Silva, M. P. Serrao, and M. A. Vieira-Coelho Apical and basolateral uptake and intracellular fate of dopamine precursor L-dopa in LLC-PK1 cells Am J Physiol Renal Physiol, February 1, 1998; 274(2): F243 - F251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ono, T. Kuwaki, M. Kumada, and T. Fujita Differential Central Modulation of the Baroreflex by Salt Loading in Normotensive and Spontaneously Hypertensive Rats Hypertension, March 1, 1997; 29(3): 808 - 814. [Abstract] [Full Text] |
||||
![]() |
D. P. O'Connell, N. V. Ragsdale, D. G. Boyd, R. A. Felder, and R. M. Carey Differential Human Renal Tubular Responses to Dopamine Type 1 Receptor Stimulation Are Determined by Blood Pressure Status Hypertension, January 1, 1997; 29(1): 115 - 122. [Abstract] [Full Text] |
||||
![]() |
V. M. Campese, M. Tawadrous, R. Bigazzi, S. Bianchi, A. S. Mann, S. Oparil, and L. Raij Salt Intake and Plasma Atrial Natriuretic Peptide and Nitric Oxide in Hypertension Hypertension, September 1, 1996; 28(3): 335 - 340. [Abstract] [Full Text] |
||||
![]() |
D. K. Wilson, L. Bayer, and D. A. Sica Variability in Salt Sensitivity Classifications in Black Male Versus Female Adolescents Hypertension, August 1, 1996; 28(2): 250 - 255. [Abstract] [Full Text] |
||||
![]() |
P. van Paassen, D. de Zeeuw, G. Navis, and P. E. de Jong Does the Renin-Angiotensin System Determine the Renal and Systemic Hemodynamic Response to Sodium in Patients With Essential Hypertension? Hypertension, February 1, 1996; 27(2): 202 - 208. [Abstract] [Full Text] |
||||
![]() |
K. Saito, H. Sano, J. Kawahara, and M. Yokoyama Calcium Supplementation Attenuates an Enhanced Platelet Function in Salt-Loaded Mildly Hypertensive Patients Hypertension, July 1, 1995; 26(1): 156 - 163. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |